✦ LIBER ✦

2FC2.1 Phase I/IIa Extension Study of PRO051/GSK2402968 in Subjects with Duchenne Muscular Dystrophy: Forty-Eight Week Safety and Efficacy Data

✍ Scribed by N. Goemans; M. Tulinius; R. Wilson; A. Morgan; C. Wardell; J. van Deutekom; S. de Kimpe; G. Campion

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O.15 24 week follow-up data from a phase

✍ N. Goemans; M. Tulinius; G. Buyse; R. Wilson; S. de Kimpe; J. van Deutekom; G. C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 39 KB

P4.27 Fourty eight-week follow-up data f

✍ N.M.L. Goemans; M. Tulinius; M. van den Hauwe; A. Kroksmark; G. Buyse; R.J. Wils 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB